Beneficial effects of propionyl L-carnitine on sarcolemmal changes in congestive heart failure due to myocardial infarction

Cardiovascular Research

Volumn 42, Issue 3, 1999, Pages 607-615

  Sethi, Rajat ^a   Dhalla, Ken S ^a   Ganguly, Pallab K ^a   Ferrari, Roberto ^b   Dhalla, Naranjan S ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Adenylate cyclase; Na+ Ca2+ exchange; Na+ K+ ATPase; Propionyl L carnitine; Rat sarcolemma

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENYLATE CYCLASE; CYCLIC AMP; PROPIONYLCARNITINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG EFFECT; ENZYME ACTIVITY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOLEMMA; SODIUM CALCIUM EXCHANGE;

ADENYLATE CYCLASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM; CARNITINE; HEART FAILURE, CONGESTIVE; MALE; MYOCARDIAL INFARCTION; NA(+)-K(+)-EXCHANGING ATPASE; RATS; RATS, SPRAGUE-DAWLEY; SARCOLEMMA; SODIUM-CALCIUM EXCHANGER; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033065819     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00089-9     Document Type: Article

References (43)

1. Corr P.B., Gross R.W., Sobel B.E. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res. 55:1984;135-154.
2. Shug A.L., Subramanian R. Modulation of adenine nucleotide translocase activity during myocardial ischemia. Z Kardiol. 76:(Suppl 5):1987;26-33.
3. Siliprandi N., Di Lisa F., Pivetta A., Miotto G., Siliprandi D. Transport and function of L-carnitine and L-propionylcarnitine: Relevance to some cardiomyopathies and cardiac ischemia. Z Kardiol. 76:(Suppl 5):1987;34-40.
4. Yang X.P., Samaja M., English E., et al. Hemodynamic and metabolic activities of propionyl-L-carnitine in rats with pressure-overload cardiac hypertrophy. J Cardiovasc Pharmacol. 20:1992;88-98.
5. Micheletti R., Giacalone G., Caneperi M., et al. Propionyl-L-carnitine prevents mechanical alterations due to pressure overload in rats. Am J Physiol. 266:1994;H2190-H2197.
6. el Alaoui-Talibi Z., Bouhaddioni N., Moravec J. Assessment of the cardiostimulant action of propionyl-L-carnitine on chronically volume-overloaded rat hearts. Cardiovasc Drugs Ther. 7:1993;357-363.
7. Micheletti R., Di Paola E.D., Schiavone A., et al. Propionyl-L-carnitine limits chronic ventricular dilation after myocardial infarction in rats. Am J Physiol. 264:1993;H1111-H1117.
8. Li P., Park C., Michelletti R., et al. Myocyte performance during evolution of myocardial infarction in rats: Effects of propionyl-L-carnitine. Am J Physiol. 268:1995;H1702-H1713.
9. +-ATPase activity in congestive heart failure due to myocardial infarction. Am J Physiol. 262:1992;C664-C671.
10. 2+-transport in congestive heart failure due to myocardial infarction in rats. Am J Physiol. 262:1992;H1387-H1394.
11. Sethi R., Dhalla K.S., Beamish R.E., Dhalla N.S. Differential changes in left and right ventricular adenylyl cyclase activities in congestive heart failure. Am J Physiol. 222:1997;H884-H893.
12. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1985;265-275.
13. Taussky H., Shorr E. A microcaloric method for the estimation of inorganic phosphorus. J Biol Chem. 202:1953;678-685.
14. Fabiato A. Computer programs for calculating total from specified total ionic concentrations of aqueous solutions containing multiple metals and ligands. Meth Enzymol. 157:1988;378-417.
15. Salmon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 58:1974;541-548.
16. 2+ exchange activity in hearts subjected to hypoxia reoxygenation. Am J Physiol. 253:1987;H1026-H1034.
17. 2+ ATPase. Prog Biophys Mol Biol. 52:1988;1-37.
18. Pierce G.N., Ramjiawan B., Dhalla N.S., Ferrari R. Na-H exchange in cardiac sarcolemmal vesicles isolated from diabetic rats. Am J Physiol. 258:1990;H255-H261.
19. Na-Ca in cardiac myocytes. Science. 248:1990;376-378.
20. 2+ ions in the mammalian myocardium and physiological significance. Circ Res. 34:1974;599-605.
21. Sethi R., Barwinsky J., Beamish R.E., Dhalla N.S. Mechanism of the positive inotropic action of insulin. J Appl Cardiol. 6:1991;199-208.
22. Bers D.M., Bassani J.W., Bassani R.A. Na-Ca exchange and Ca fluxes during contraction and relaxation in mammalian ventricular muscle. Ann NY Acad Sci. 779:1996;430-442.
23. Mubagwa K., Lin W., Sipido K., Bosteels S., Flameng W. Monensin-induced reversal of positive force-frequency relationship in cardiac muscle: role of intracellular sodium in rest-dependent potentiation of contraction. J Mol Cell Cardiol. 29:1997;977-989.
24. 2+ exchanger in mammalian cardiac myocytes. J Physiol. 488:1995;623-631.
25. Yashar P.R., Fransua M., Frishman W.H. The sodium-calcium ion membrane exchanger: physiologic significance and pharmacologic implications. J Clin Pharmacol. 38:1998;393-401.
26. Hasenfuss G., Meyer M., Schillinger W., Preuss M., Pieske B., Just H. Calcium handling proteins in the failing human heart. Basic Res Cardiol. 92:(Suppl 1):1997;87-93.
27. 2+ currents in compensated hypertrophy and heart failure. Cardiovasc Res. 37:1998;300-311.
28. 2+ exchange activity in patients with end-stage heart failure. Cardiovasc Res. 31:1996;48-54.
29. 2+-exchanger in end-stage human heart failure. Circ Res. 75:1994;443-453.
30. 2+-exchanger in failing human myocardium. Circulation. 94:1996;992-1002.
31. Calderone A., Bouvier M., Li K., et al. Dysfunction of the beta and alpha adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ Res. 69:1991;332-343.
32. Feldman A.M., Cates A.E., Veazey W.B., et al. Increase of the 40 000 mol wt pertussis toxin substrate (G protein) in the failing heart. J Clin Invest. 82:1988;189-197.
33. Alam S.Q., Alam B.S., Ren Y.F. Adenylate cyclase activity, membrane fluidity and fatty acid composition of rat heart in essential fatty acid deficiency. J Mol Cell Cardiol. 19:1987;465-475.
34. Haugland B., Louis R.P., Musch S.L., Waldeck N., Williams M.A. Liver plasma membranes from essential fatty acid deficient rats. Isolation, fatty acid composition, and activities of 5′-nucleotidase, ATPase and adenylate cyclase. Biochem Biophys Acta. 433:1976;150-163.
35. Anand-Srivastava M.B. Altered responsiveness of adenylate cyclase to adenosine and other agents in the myocardial sarcolemma and aorta of spontaneously-hypertensive rats. Biochemical Pharmacol. 37:1988;3017-3022.
36. Dhalla N.S., Kolar F., Shah K.R., Ferrari R. Effects of some L-carnitine derivatives on heart membrane ATPases. Cardiovasc Drugs Ther. 5:1991;25-30.
37. Bevilacqua M., Vago M., Norbiato G. Effect of propionyl-L-carnitine on L-type calcium channels in human sarcolemma. Cardiovasc Drugs Ther. 1:1991;31-35.
38. el Alaoui-Talibi Z., Guendouz A., Moravec M., Moravec J. Control of oxidative metabolism in volume-overloaded rat hearts: effects of propionyl L-carnitine. Am J Physiol. 272:1997;H1615-H1624.
39. Torielli L., Conti F., Cinato E., et al. Alterations in energy metabolism of hypertrophied rat cardiomyocytes: Influence of propionyl-L-carnitine. J Cardiovasc Pharmacol. 26:1995;372-380.
40. Kawasaki N., Lee J.D., Shimizu H., Ueda T. Long-term L-carnitine treatment prolongs the survival in rats with adriamycin-induced heart failure. J Cardiac Failure. 2:1996;293-299.
41. Liedtke A.J., De Maison L., Nellis H. Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts. Am J Physiol. 255:1988;H169-H176.
42. Packer L., Valenza M., Serbinova E., Starke-Reed P., Frost K.K. Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart. Arch Biochem Biophys. 288:1991;533-537.
43. Ronca G., Ronca F., Yu -G., Zuchi R., Bertelli A. Protection of isolated perfused working rat heart from oxidative stress by exogenous L-propionyl carnitine. Drugs Exp Clin Res. 18:1992;475-480.